MAYWOOD, Ill. - Loyola University Chicago researcher Jeanine Walenga, PhD, has received a top award from the Chicago chapter of the American Association for Clinical Chemistry.
Walenga, who researches bleeding and blood clot disorders, received the Samuel R. Natelson Research Award, which recognizes scientists who have "contributed a significant body of work throughout their career that has had a scientific impact on the profession."
Walenga is a professor in the departments of Thoracic & Cardiovascular Surgery and Pathology of Loyola University Chicago Stritch School of Medicine. She has been at Loyola for 33 years.
Walenga has helped develop laboratory methods to diagnose bleeding and clotting disorders, and has contributed to the development of new methods to monitor blood-thinning drugs. Her research also has led to the development of new anti-clotting medications, such as fondaparinux (Arixtra®).
She is internationally recognized for her pioneering work in the laboratory diagnosis of heparin-induced thrombocytopenia, or HIT. (Heparin is an anti-clotting drug, thrombocytopenia is an abnormal drop in blood cells involved in forming blood clots and HIT is an immune reaction to heparin.)
"Her scientific work is widely quoted and she has served as an expert to the U.S. Pharmacopeia and many professional organizations," said Jawed Fareed, PhD, director of Loyola's Hemostasis and Thrombosis Research Program.